Discover
ACCP JOURNALS
ACCP JOURNALS
Author: ACCP JOURNALS
Subscribed: 120Played: 2,218Subscribe
Share
© ACCP JOURNALS
Description
This podcast brings you interviews with journal authors providing insight on their recent publication in an official journal of the American College of Clinical Pharmacy. Pharmacotherapy publishes advances in human pharmacology and drug therapy and the JACCP publishes innovations in clinical pharmacy practice.
ACCP JOURNALS DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.
ACCP JOURNALS DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.
193 Episodes
Reverse
In this episode of the JACCP Podcast, host Jennifer Cocohoba speaks with Dr. Anthony Hawkins, clinical professor and critical care pharmacist at the University of Georgia College of Pharmacy, about applying cognitive apprenticeship to pharmacy experiential education. They explore how preceptors can make clinical reasoning visible, discuss unwritten rules of interprofessional collaboration, and outline the importance of tailoring learning experiences to trainees’ prior experiences and needs. Dr. Hawkins shares practical strategies for preceptors seeking to enhance student and resident learning without overhauling their entire rotation. Read the full OPEN ACCESS article at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70302
Dr. Janelle Perkins, guest editor for the themed issue on Women’s Health in Oncology highlights cancer care challenges specific to women across life stages (menarche, pregnancy, breastfeeding, menopause), including infertility, early menopause, fetal/newborn risks, contraception, and menopausal care, and emphasizes individualized, goal-driven patient–provider discussions. They discuss fertility and reproductive management during treatment, differences among cytotoxic chemotherapy, hormonal agents such as aromatase inhibitors, targeted therapies, and immune checkpoint inhibitors, and communication to clarify expectations and side effects. Perkins summarizes emerging observational data on GLP-1 receptor agonists during breast cancer treatment, including possible cardioprotective benefits amid GI side-effect concerns. Read the full issue at: https://accpjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1875-9114.womens-health-in-oncology
Are clinical metrics measuring what actually matters? In this episode, JACCP Editor-in-Chief Stuart Haines and new Associate Editor Ty Kiser sit down with Andrea Sikora and Brian Murray (University of Colorado) to discuss their editorial "Keeping the Good in Goodhart's Law: Bridging Key Performance Indicators to Comprehensive Medication Management," written in response to the Clinical Administration PRN Opinion Paper that proposes 15 key performance indicators (KPIs) for clinical pharmacy practice. Drawing on Goodhart's Law and McNamara's Fallacy, Sikora and Murray warn that easy-to-measure tasks like IV-to-PO conversion can crowd out the harder-to-quantify cognitive work of comprehensive medication management (CMM). Using vivid stories from the ICU, they make the case for pairing pharmacist-facing KPIs with structural accountability measures that protect time for the work that matters most.
This episode focuses on missed opportunities to intensify lipid-lowering therapy, highlighting gaps where treatment escalation could improve lipid management and cardiovascular risk reduction. The discussion centers on recognizing when lipid control is inadequate and on the role of the clinical pharmacist in optimizing medications, including PCSK9i, statins, and emerging therapies, to better align with patient risk and treatment goals. Read the full article at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70209
Drs. Shannon Finks and Sarah McBane discuss their July 2026 narrative review, “Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence.” They describe menopause as a multisystem transition with vasomotor, mood/cognitive, cardiometabolic, and genitourinary symptoms, noting many women see multiple clinicians before diagnosis. They emphasize that menopausal hormone therapy (MHT) formulation, route, timing, and patient selection matter. They discuss MHT benefits for symptom relief, bone protection, and genitourinary symptoms, nuances around cardiovascular, cancer, and cognition outcomes, FDA labeling updates, and more. The manuscript is available at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70178







